.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Dow
Federal Trade Commission
Fish and Richardson
Chinese Patent Office
Accenture
Queensland Health
Cerilliant
QuintilesIMS
Medtronic

Generated: September 21, 2017

DrugPatentWatch Database Preview

Patents Expiring in July 2019

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis
EXFORGE
amlodipine besylate; valsartan
TABLET;ORAL021990-003Jun 20, 2007ABRXYesYes► Subscribe► SubscribeY
Novartis
EXFORGE
amlodipine besylate; valsartan
TABLET;ORAL021990-004Jun 20, 2007ABRXYesNo► Subscribe► SubscribeY
Novartis
EXFORGE
amlodipine besylate; valsartan
TABLET;ORAL021990-002Jun 20, 2007ABRXYesNo► Subscribe► SubscribeY
Novartis
EXFORGE
amlodipine besylate; valsartan
TABLET;ORAL021990-005Jun 20, 2007ABRXYesYes► Subscribe► SubscribeY
J And J Consumer Inc
ZYRTEC-D 12 HOUR
cetirizine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL021150-002Nov 9, 2007OTCYesYes► Subscribe► SubscribeY TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS
Depomed Inc
ZIPSOR
diclofenac potassium
CAPSULE;ORAL022202-001Jun 16, 2009ABRXYesYes► Subscribe► SubscribeY NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN
Shire Orphan Therap
FIRAZYR
icatibant acetate
INJECTABLE;SUBCUTANEOUS022150-001Aug 25, 2011RXYesYes► Subscribe► SubscribeYY TREATMENT OF PATHOLOGICAL STATE BY ANTAGONIZING BRADYKININ RECEPTOR INCLUDING TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA (HAE)
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-005Oct 8, 2013RXYesYes► Subscribe► SubscribeYY
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-004Oct 8, 2013RXYesNo► Subscribe► SubscribeYY
Bayer Hlthcare
ADEMPAS
riociguat
TABLET;ORAL204819-003Oct 8, 2013RXYesNo► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
AstraZeneca
Accenture
Harvard Business School
Julphar
US Army
Daiichi Sankyo
Healthtrust
Cerilliant
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot